课题基金 / 基金详情

Mentoring Early-Career Scientists for Drug Abuse Research Careers

Mentoring Early-Career Scientists for Drug Abuse Research Careers
指导早期职业科学家的药物滥用研究职业
批准号:
9480125
负责人:
Carmen L Masson
金额:
$1.3万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-05-01 至 2019-04-30

项目摘要

项目成果

Carmen L Masson的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):在寻求NIH研究资金的申请者中,以及在R01 NIH资助的研究人员中,种族/少数民族代表不足。成瘾和多样性早期职业学习(LEAD)计划为来自代表不足的群体或弱势背景的早期研究科学家提供培训,旨在增加在药物滥用治疗中进行行为或药物治疗研究的种族/少数民族人数。Lead建立在国家药物滥用临床试验网络(CTN)的平台上,这是一个由科学家和治疗提供者组成的网络,为以科学为基础的疗法的多地点测试提供了广泛的基础设施。这个 培训计划还受益于与加州大学旧金山分校(UCSF)进行临床研究的培训计划和教员的密切联系,以及加州大学旧金山分校临床和翻译科学研究所的存在。我们的具体目标是:1)将实习学者与CTN的资深科学家相匹配,他们将提供科学指导和专业指导;2)为学者提供支持,以进行试点研究,作为后续NIH申请的途径;3)协助学者发展拨款撰写技能,目标是在领先培训期间提交竞争性的NIH申请;4)提供循证治疗文化定制方面的培训;5)向学者提供知识和技能,以解决临床试验中遇到的伦理、法规和项目管理问题;以及6)提供网络结构,以建立与药物滥用临床试验研究中的领先专家的关系。学者将参加为期3年的培训,包括每年4周的夏季强化计划,在加州大学旧金山分校举行研讨会和会议,在学年期间进行指导和培训,并参加CTN全国研究和培训会议。学者将与NIDA CTN高级调查人员配对,他们将在为期3年的培训期内指导他们。在第一年,学者们将设计并完成一项由资金支持的试点 学习,参加研讨会,帮助他们制定可资助的赠款提案,并参加CTN培训,以了解当前的研究主题,并与国家药物使用研究领域的领导者建立网络。在他们的第二年,培训将集中在赠款的编写上,包括初步 来自指导项目的数据,用于支持培训(即K)或研究(即R03、R21或R01) 对NIDA的申请。在第三年,培训的重点将是重新提交国家卫生研究院的申请,如有必要,准备出版手稿,并在科学会议上传播研究成果,包括CTN指导委员会年度会议。成功的研究或职业发展奖是为参与该计划的9名早期调查人员计划的可衡量的结果。该计划满足了对在美国不同样本中进行具有文化能力的药物滥用治疗研究的专业知识的调查人员的需求。长期目标是增加进行药物滥用研究的少数群体中代表不足的个人的数量。
英文摘要
DESCRIPTION (provided by applicant): Racial/ethnic minorities are underrepresented among applicants seeking NIH research funding and among R01 NIH-funded researchers. The Learning for Early Careers in Addiction and Diversity (LEAD) program provides training to early-stage research scientists from underrepresented groups or disadvantaged backgrounds, aiming to increase the number of racial/ethnic minorities who conduct behavioral or pharmacological treatment research in drug abuse treatment. LEAD builds on the platform of the National Institute on Drug Abuse Clinical Trials Network (CTN), a network of scientists and treatment providers that offers a broad infrastructure for multi-site testing of science-based therapies. The training program also benefits from strong connections to training programs and faculty conducting clinical research at University of California San Francisco (UCSF) and the presence of the UCSF Clinical and Translational Science Institute. Our specific aims are to: 1) Match trainee scholars with senior scientists in the CTN who will provide scientific mentoring and professional guidance, 2) provide scholars with support to conduct pilot research as a pathway to subsequent NIH applications, 3) assist scholars in developing grant-writing skills, with the goal of submitting competitive NIH applications during the LEAD training period, 4) offer training in cultural tailoring of evidence-based treatments, 5) provide scholars with knowledge and skills to address ethical, regulatory, and project management issues encountered in clinical trials, and 6) provide a networking structure to build relationships with leading experts in drug abuse clinical trials research. Scholars will participate in a 3-year training, consisting of a yearly 4-eek summer intensive program of seminars and meetings at UCSF, mentoring and training during the academic year, and participation in CTN national research and training meetings. Scholars will be matched with NIDA CTN senior investigators who will mentor them through the 3-year training period. In the first year, scholars will design and complete a financially supported pilot study, attend seminars to help them develop fundable grant proposals, and participate in CTN trainings to learn about current research topics and to network with national leaders in drug use research. In their second year, training will be focused on grant-writing incorporating preliminary data from the mentored project to support a training (i.e., K) or research (i.e., R03, R21, or R01) application to NIDA. In the third year, training will be focused on the re-submission of NIH applications, if necessary, preparation of manuscripts for publication, and dissemination of research findings at scientific meetings including the annual CTN Steering Committee meeting. A successful award for research or career development is the planned measurable outcome for the 9 early-stage investigators who participate in the program. The program addresses the need for investigators who have expertise in conducting culturally-competent drug abuse treatment research in diverse samples in the U.S. The long-term goal is to increase the number of PIs from underrepresented minority groups conducting drug abuse research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Expanding Access to Buprenorphine Treatment among Homeless Persons with Opioid Use Disorder
Digital Health Technology Use Among Methadone Maintenance Patients
Digital Health Technology Use Among Methadone Maintenance Patients
Mentoring Early-Career Scientists for Drug Abuse Research Careers
海外基金